NIH Research Matters
November 2008 Archive
November 24, 2008
Three new studies provide the strongest evidence to date that a simple blood test for a molecule called C-reactive protein (CRP) could help clinicians better identify and treat people who are at risk for cardiovascular disease.
The dietary supplement Ginkgo biloba was found to be ineffective in reducing the development of dementia and Alzheimer's disease in older people, according to a new study.
A new brain imaging study has found that elderly people can develop a key hallmark of Alzheimer’s disease in the brain without any evidence of cognitive impairment. The researchers hope that their detection method will one day help predict who will develop Alzheimer’s disease in 5 to 10 years.
November 10, 2008
A new study has found that early treatment to prevent severe jaundice in extremely early preterm infants can reduce the rate of brain injury, a serious complication of jaundice.
Young adults addicted to opioids were more successful at remaining drug-free when they received 12 weeks of treatment with the combination medication buprenorphine-naloxone than those who received the same treatment for only 2 weeks. The findings suggest that longer-term pharmacological treatment, along with counseling, could be beneficial to adolescents who want to break their opioid addictions.
A new study has found that the majority of children with egg allergy may be able to eat some baked foods containing egg. The early results also raise the possibility that the gradual introduction of extensively heated egg may help alleviate some children's allergy to regular egg.
October 3, 2008
We often use terms like “warm” and “cold” to describe people. New research shows this may not just be a linguistic oddity; sensations and psychological concepts are actually linked in our minds.
Researchers have found that most fat cells arise from cells in the walls of blood vessels in fat tissue. This insight may lead to new approaches to prevent and treat obesity.
Scientists have identified a disrupted molecular pathway that leads to fatigue after even mild physical exertion in mice with muscular dystrophy. This fatigue can be relieved by giving the animals a drug that bypasses the disruption. The finding may lead to a better understanding of the post-activity exhaustion that strikes many people who have neuromuscular disorders.
NIH Research Matters
Bldg. 31, Rm. 5B64A, MSC 2094
Bethesda, MD 20892-2094
About NIH Research Matters
Harrison Wein, Ph.D., Editor
Vicki Contie, Assistant Editor
NIH Research Matters is a weekly update of NIH research highlights from the Office of Communications and Public Liaison, Office of the Director, National Institutes of Health.